reviewThe LancetAug 1, 2005GREEN OA

NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses

MGMontserrat García‐ClosasNMNúria MalatsDTDebra T. SilvermanMDMustafa DosemeciMKManolis Kogevinas

National Cancer Institute · Municipal Institute for Medical Research · +5 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

630
total citations
FWCI
18.45
Percentile
100%
References
72
Citations per year

Authors

22

Topics & keywords

Topics
Keywords
  • Bladder cancer
  • Genotype
  • Odds ratio
  • Meta-analysis
  • Medicine
  • Cancer
  • GSTP1
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.